CDKN2A and urothelial carcinoma: In this study, we collected 259 cases of urothelial carcinomas, compared the changes in expression of p16 gene and its protein levels in urine samples, and evaluated the predictive value of p16 gene statusin urothelial carcinoma of the urinary bladder.